Mirum Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $133,009 | $127,785 | $111,585 | $99,414 |
Gross Profit | 107,473 | 104,364 | 88,567 | 76,634 |
EBITDA | 9,060 | 4,186 | -4,000 | -14,731 |
EBIT | 2,998 | -1,870 | -10,052 | -20,787 |
Net Income | 2,905 | -5,861 | -14,677 | -23,790 |
Net Change In Cash | 133,009 | 127,785 | 111,585 | 99,414 |
Free Cash Flow | 39,494 | 11,914 | -2,002 | -5,088 |
Cash | 282,021 | 228,122 | 211,822 | 222,503 |
Basic Shares | 56,993 | 49,726 | 48,889 | 48,338 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $336,888 | $186,374 | $77,062 | $19,138 |
Gross Profit | 255,245 | 139,335 | 64,688 | 17,235 |
EBITDA | -48,972 | -136,490 | -122,854 | -65,386 |
EBIT | -72,601 | -147,319 | -126,092 | -66,361 |
Net Income | -87,942 | -163,415 | -135,665 | -83,988 |
Net Change In Cash | 336,888 | 186,374 | 77,062 | 19,138 |
Cost of Revenue | -3,349 | -10,745 | ||
Free Cash Flow | 9,332 | -91,053 | -120,414 | -151,782 |
Cash | 222,503 | 286,326 | 28,003 | 31,340 |
Basic Shares | 47,523 | 40,885 | 33,982 | 30,321 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | $0 |
2025-09-30 | $0.05 |
2025-06-30 | -$0.12 |
2025-03-31 | -$0.30 |
